Menu
Back to User profile » Professor Reiji Yoshimura
Papers published by Professor Reiji Yoshimura:
Increased Stimulation Intensity Helped to Cope with Prolonged Seizures During the Next Round of Modified Electroconvulsive Therapy: A Case Report
Katsumura T, Okamoto N, Tesen H, Igata R, Ikenouchi A, Yoshimura R
International Medical Case Reports Journal 2022, 15:385-387
Published Date: 22 July 2022
Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study
Ikenouchi A, Konno Y, Fujino Y, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R
Neuropsychiatric Disease and Treatment 2022, 18:801-809
Published Date: 8 April 2022
Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation
Hoshikawa T, Okamoto N, Natsuyama T, Fujii R, Ikenouchi A, Honma Y, Harada M, Yoshimura R
Neuropsychiatric Disease and Treatment 2022, 18:173-186
Published Date: 3 February 2022
Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project
Konno Y, Fujino Y, Ikenouchi A, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R
Neuropsychiatric Disease and Treatment 2021, 17:2867-2876
Published Date: 7 September 2021
A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
Yoshimura R, Ikenouchi A, Okamoto N, Konishi Y
International Medical Case Reports Journal 2021, 14:271-273
Published Date: 28 April 2021
A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report
Okamoto N, Konishi Y, Tesen H, Ikenouchi A, Yoshimura R
International Medical Case Reports Journal 2021, 14:237-239
Published Date: 16 April 2021
Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study
Okamoto N, Watanabe K, Ngyuyen LH, Ikenouchi A, Kishi T, Iwata N, Kakeda S, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2020, 16:2569-2577
Published Date: 29 October 2020
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)
Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K
Neuropsychiatric Disease and Treatment 2020, 16:881-890
Published Date: 31 March 2020
Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
Yoshimura R, Kishi T, Iwata N
Neuropsychiatric Disease and Treatment 2019, 15:2655-2661
Published Date: 13 September 2019
A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder
Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2019, 15:2425-2432
Published Date: 23 August 2019
COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder
Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2019, 15:1537-1545
Published Date: 6 June 2019
Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms
Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y
Neuropsychiatric Disease and Treatment 2019, 15:375-383
Published Date: 29 January 2019
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Neuropsychiatric Disease and Treatment 2018, 14:2519-2530
Published Date: 1 October 2018
Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
Yoshimura R, Katsuki A, Atake K, Hori H, Igata R, Konishi Y
Neuropsychiatric Disease and Treatment 2017, 13:437-441
Published Date: 14 February 2017
Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
Atake K, Yoshimura R, Hori H, Katsuki A, Nakamura J
Neuropsychiatric Disease and Treatment 2015, 11:967-974
Published Date: 3 April 2015
Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study
Nishimura J, Kakeda S, Abe O, Yoshimura R, Watanabe K, Goto N, Hori H, Sato T, Takao H, Kabasawa H, Nakamura J, Korogi Y
Neuropsychiatric Disease and Treatment 2014, 10:2315-2323
Published Date: 8 December 2014
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
Hayashi K, Yoshimura R, Kakeda S, Kishi T, Abe O, Umene-Nakano W, Katsuki A, Hori H, Ikenouchi-Sugita A, Watanabe K, Ide S, Ueda I, Moriya J, Iwata N, Korogi Y, Kubicki M, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:1183-1190
Published Date: 25 June 2014
Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:527-533
Published Date: 26 March 2014
Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
Goto N, Yoshimura R, Kakeda S, Nishimura J, Moriya J, Hayashi K, Katsuki A, Hori H, Umene-Nakano W, Ikenouchi-Sugita A, Korogi Y, Nakamura J
Neuropsychiatric Disease and Treatment 2012, 8:119-122
Published Date: 3 April 2012
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, Yuki Kodama, Wakako Umene-Nakano, Jun Nakamura
Neuropsychiatric Disease and Treatment 2008, 4:1277-1281
Published Date: 5 December 2008